首页> 外国专利> THERAPEUTIC AGENT FOR NON-MOTOR SYMPTOMS ASSOCIATED WITH PARKINSON'S DISEASE

THERAPEUTIC AGENT FOR NON-MOTOR SYMPTOMS ASSOCIATED WITH PARKINSON'S DISEASE

机译：帕金森氏病相关的非运动症状治疗剂

页面导航

摘要
著录项
相似文献

摘要

The purpose of the present invention is to provide: a therapeutic agent or a recurrence preventive agent for serotonergic system- or dopaminergic system-related diseases, in particular, mental dysfunction symptoms and other non-motor symptoms of Parkinson's disease; and a method for treating the aforesaid symptoms or preventing the recurrence of the same. A compound represented by formula (1) [wherein each symbol is as defined in the description] or a pharmaceutically acceptable salt thereof can exhibit an effect of treating serotonergic system- or dopaminergic system-related diseases, in particular, mental dysfunction symptoms and other non-motor symptoms of Parkinson's disease and/or an effect of preventing the recurrence of the same.

机译：本发明的目的是提供：用于治疗与血清素能系统或多巴胺能系统有关的疾病，特别是精神功能障碍症状和帕金森氏病的其他非运动症状的治疗剂或复发预防剂。以及用于治疗上述症状或防止其复发的方法。由式（1）表示的化合物[其中每个符号如说明书中所定义]或其药学上可接受的盐可显示出治疗与血清素能系统或多巴胺能系统有关的疾病的作用，特别是精神功能障碍症状和其他非-帕金森氏病的运动症状和/或预防帕金森氏病复发的作用。

著录项

公开/公告号EP3569233A4

专利类型
公开/公告日2020-09-30

原文格式PDF
申请/专利权人 SUMITOMO DAINIPPON PHARMA CO. LTD.;
展开▼

申请/专利号EP20180739127
发明设计人 KATO TARO;SHIMIZU SATOKO;
展开▼

申请日2018-01-12
分类号A61K31/415;A61K31/4155;A61K45;A61K45/06;A61P25/16;A61P25/18;A61P25/20;A61P25/22;A61P25/24;A61P25/28;A61P43;
国家 EP
入库时间 2022-08-21 11:41:25

相似文献

专利
外文文献
中文文献